Purpose: Fixed beam radiotherapy systems utilize couch movement and rotation instead of gantry rotation in order to simplify linear accelerator design. We investigate the ability to deliver fixed beam treatments with the same level of clinical accuracy as conventional (rotating beam) treatments using real-time image guidance to maintain this accuracy in the presence of rigid target motion. Methods: A prototype fixed beam radiotherapy system was built using a standard linac with the beam fixed in the vertical position and a computer controlled rotation stage that rotated a rigid phantom about the superior-inferior axis. Kilovoltage Intrafraction Monitoring (KIM) and real-time beam adaptation with MLC tracking was applied to a five-field IMRT treatment plan with motion introduced to the phantom. The same IMRT treatment was also delivered with real-time adaptation using the conventional rotating beam geometry. Film dosimetry was used to measure the dose delivered with a fixed beam compared to a rotating beam, as well as to compare treatments delivered with and without real-time adaptation. Results: The dose distributions were found to be equivalent between the fixed beam and rotating beam geometry for real-time adaptive radiotherapy using KIM and MLC tracking beam adaptation. Gamma analysis on the films showed agreement >98% using a 2%/2 mm criteria with adaptation for static shifts and periodic motion. Conclusions: Fixed beam treatments with real-time beam adaptation are dosimetrically equivalent to conventional treatments with a rotating beam, even in the presence of rigid target motion. This suggests that, for a rigid target, the high clinical accuracy of real-time adaptive radiotherapy can be achieved with simpler beam geometry.
INTRODUCTION
Radiotherapy is a fundamental part of cancer treatment and is recommended for half of all patients with cancer. 1 However, it is estimated that there are currently just 13,956 radiotherapy machines worldwide and an estimated 21,800 additional machines will needed by 2030 to meet demand. 2 The global shortfall in radiotherapy has been caused in part by the large capital requirements, operation costs, complexity in implementation and staffing required to setup and maintain a radiotherapy facility. 3 One approach to improving global access to radiotherapy is the development of smaller and simpler treatment systems, such as those with a fixed radiation beam. 4 A fixed radiation beam negates the costs and the engineering challenges of rotating the heavy components of the gantry with high accuracy and results in a machine with fewer moving parts to break down. Rotation of the target should allow the same beam geometries and dose distributions to be achieved. The smaller footprint and lower shielding requirements relative to rotating gantry linacs can provide further economic benefits by allowing linacs to be installed in smaller bunkers or in existing Co-60 bunkers. 5 Real-time image guidance and beam adaptation are emerging as crucial components of a patient-centered and automated treatment paradigm. Kilovoltage Intrafraction Monitoring (KIM) and MLC tracking are technologies that monitor and compensate for target motion. KIM is a real-time target localization method that utilizes the gantry-mounted onboard kV imager (OBI) to track the 3D position of implanted fiducial markers. 6, 7 KIM has been used to monitor over 1,200 fractions for prostate cancer across five cancer centers. 8 MLC tracking is a beam adaptation method that recalculates MLC leaf positions in real-time based on target location. 9 MLC tracking has been used to treat over 800 fractions for prostate and lung cancer. 10 Both techniques have been clinically implemented using a Varian Trilogy linac, providing real-time image-guided adaptive radiotherapy to account for rigid motion. 11 The purpose of this study was to demonstrate the feasibility of a fixed beam treatment system with real-time image guidance and beam adaptation. Our first aim is to show equivalence between the dose distributions from a rotating beam treatment (where the treatment beam rotates about a static target) and a fixed beam treatment (where the target rotates under a static, vertical treatment beam). Our second aim is to validate KIM and MLC tracking algorithms for a fixed beam treatment and show that these techniques can account for target motion under rotation in all three spatial dimensions.
MATERIALS AND METHODS
A prototype fixed beam radiotherapy system was built with two components: a standard Varian Trilogy linac (Varian Medical Systems, Palo Alto, CA, USA) and a rotating platform. The linac was kept stationary at 0°to simulate a fixed vertical beam. KIM and MLC tracking algorithms were used with the linac's onboard kV imaging system to enable realtime image guidance and beam adaptation. To demonstrate the fixed beam concept, an IMRT plan was delivered using this prototype system, both with and without target motion. The dose distribution delivered using the fixed beam method was measured and compared to that delivered using the conventional rotating gantry method.
2.A. Phantom rotation
An acrylic phantom containing three embedded fiducial markers surrounding a 2.15 cm 3 epoxy tumor analog was securely mounted on a rotating platform (described throughout as the phantom rotation platform). The phantom rotation platform (Fig. 1) is a custom-designed, computer controlled device designed to rotate about the superior-inferior axis. The platform acts as a miniature prototype of a horizontal patient rotation system. The phantom rotation platform was placed under the Trilogy linear accelerator such that its axis of rotation was aligned with the axis of rotation of the gantry, that is, the treatment isocenter. The centroid of the three markers represents the centre of mass of the tumor target and was also aligned with the treatment isocenter.
The alignment of the axis of rotation to the gantry isocenter was confirmed prior to irradiation. At discrete angles, images of the phantom were taken with the on-board imager (OBI) by rotating the gantry and then repeated by rotating the phantom with the gantry at 0°. The average difference between the marker positions in images taken by rotating the gantry and in corresponding images taken by rotating the phantom across all angles was measured to be 0.38 AE 0.11 mm, with a maximum difference of 0.63 AE 0.10 mm. The misalignment between the phantom rotation platform and the gantry isocenter causes an additional uncertainty in the position of the target measured using KIM with a fixed kV imager. The average uncertainty in the position of the target was measured to be 0.34 AE 0.31 mm with a maximum difference of 0.77 mm.
2.B. Treatment delivery
A 6 MV x ray IMRT plan was created to deliver 6 Gy to a CTV delineated around the tumor target. The plan consisted of five fields with gantry angles of 0°, 60°, 110°, 250°, 310°(the rotating beam treatment) and a dose rate of 600 MU min
À1
. A modified version of this plan (the fixed beam treatment) was created with the same treatment fields but with a fixed gantry angle of 0°. Both the rotating beam treatment and the fixed beam treatment were delivered on the same linac with the same radiation beam and with the phantom and rotation platform set up in the same position. While the rotating beam treatment was delivered conventionally, the fixed beam treatment was delivered by rotating the phantom between treatment fields to the desired angle [ Fig. 2(b) ]. To investigate the dosimetric equivalence between the rotating beam and fixed beam treatments, both treatment plans were delivered to the phantom with the center of the target located at the radiation isocenter.
2.C. Kilovoltage intrafraction monitoring and MLC tracking
Real-time image guidance was applied to monitor both static and dynamic movements of the phantom during a fixed beam treatment. For static movements, the phantom was alternately shifted away from the isocenter 4.0 mm along the superior-inferior (SI) axis, À5.0 mm along the left-right (LR) axis and À5.0 mm along the anterior-posterior (AP) axis. As shown in Fig. 2 , the phantom was shifted on the phantom rotation platform while the platform's axis of rotation remained aligned with the gantry isocenter at all times. For dynamic movements, the phantom rotation platform was placed on a 1D translation platform that moved the target periodically along the SI axis. The target was moved in a sinusoidal motion with a range of 10 mm (peak-to-trough) and a period of 6 s, replicating the range of lung tumor motion. 12 Kilovoltage Intrafraction Monitoring (KIM) was used to monitor the position of the target during treatment delivery. KIM is a marker based tracking algorithm that estimates the 3D position of a target from 2D x ray projections taken by the gantry-mounted OBI. 6 The KIM workflow for a rotating beam and rotating OBI is described in detail in Keall et al. 13 For fixed beam treatments, KIM was adapted by replacing the gantry angle in the algorithm with the angle of the phantom rotation platform. As with a rotating beam treatment, a 3D probability density function (PDF) was obtained prior to treatment delivery. To obtain the PDF, fluoroscopic images are acquired at 11 Hz as the phantom is rotated in a 120°p re-treatment arc. The exposure parameters used were 80 kVp, 80 mA, 13 ms and a 6 9 6 cm 2 field size. Images continue to be acquired during treatment delivery as the phantom rotates to the specified angle for each IMRT field. The 3D position of the target is reconstructed in real-time by maximum likelihood estimation of the prior PDF.
To track the target, the target position from KIM is used as input to the MLC tracking algorithm that dynamically adapts the leaf positions of the 120-leaf Millennium MLC. 9 Based on this position and the angle of the phantom rotation platform, the leaf positions in the original treatment plan are modified to translate the beam aperture to the appropriate location. For a dynamically moving target, a kernel density based prediction algorithm was applied to estimate the future position of the target after image acquisition. 14 The latency with which the updated leaf positions were sent to the MLC controller was measured to be 230 AE 20 ms. The effectiveness of KIM and MLC tracking for a target under rotation was measured by comparing the dose distribution about a shifted or dynamically moving target to the dose distribution delivered to a static target at the isocenter.
2.D. Dosimetric evaluation
The dose delivered to the phantom was measured using EBT3 film placed between two halves of the tumor target, perpendicular to the beam central axis at gantry 0°. Film analysis was performed by the method described in Devic et al. 15 Each piece of EBT3 film was scanned prior to irradiation using an Epson V700 flatbed scanner (SEIKO Epson Co, Japan) in transmission mode with 48-bit RGB and a scanner resolution of 72 dpi. Following irradiation, the film was left for at least 24 h and scanned with identical settings. The ratio of red channel pixel values from the pre-irradiated film to the irradiated film was calculated for each pixel. The optical density of each pixel was calculated by taking the log 10 of this ratio. The optical density maps were smoothed using a Weiner filter with 3 9 3 pixel neighborhood size, then related to dose using a calibration curve relating optical density to dose obtained in the same measurement session. Dose values were normalized to the average value of a 5 9 5 mm 2 area surrounding the beam central axis. Dosimetric comparison between films was performed by analyzing inplane and cross-plane dose profiles and by performing a 2D gamma analysis using a 2%/2 mm criteria for areas of the film receiving greater than 20% of the maximum dose. Figure 3 shows the inplane and cross-plane dose profiles of the fixed beam treatment compared to the rotating beam treatment and the treatment planning system. For these measurements, the target was located at the isocenter and motion tracking was not used. Gamma analysis between the two films showed 100% pass rate using a 2%/2 mm criteria. These results demonstrate dosimetric equivalence between these two treatment geometries for a target located at the isocenter.
RESULTS

3.A. Dosimetric equivalence between rotating beam and fixed beam treatments
Rotating gantry treatment (a)
Fixed beam treatment When KIM and MLC tracking are used, the dose profiles around the shifted targets visually show good agreement with the dose profiles delivered to the target at isocenter. This indicates that MLC tracking has successfully compensated for these movements as the phantom is rotated and the dose distribution about the target is maintained.
Gamma analysis of the dose distributions achieved with KIM and MLC tracking showed high pass rates using the 2%/2 mm criteria. When compared to a rotating beam treatment where the target is positioned at the isocenter, the pass rates were 100%, 99.4%, and 99.8%, respectively. When compared to a fixed beam treatment where the target is positioned at the isocenter, the pass rates for the SI, LR and AP shifted targets were 99.0%, 99.3%, and 99.8%, respectively. Figure 5 shows the dose profiles when KIM and MLC tracking are used to follow a target moving with a periodic motion in the SI direction. For both rotating beam and fixed beam geometries, the dose profiles with MLC tracking show good agreement with the dose profile of a static treatment. Gamma analysis of the dose distributions compared to the static case had pass rates of 98.7% and 99.7% for the rotating beam and fixed beam geometries, respectively, using the 2%/ 2 mm criteria. This demonstrates the effectiveness of MLC tracking, as the same treatment delivered without MLC tracking would have resulted in a pass rate of 90.1%.
3.C. MLC tracking for dynamic motion
The use of MLC tracking reduces the broadening of the beam penumbra that occurs as a result of tumor motion and can cause under-dosing of the target. Without motion compensation, the average width of the beam penumbra (80%-20%) along the axis of motion increases from 4.7 to 9.3 mm due to target motion. When MLC tracking is used, the width of the penumbra is 5.2 mm in the case of a rotating gantry treatment and 5.9 mm in the case of the rotating target treatment.
DISCUSSION AND CONCLUSION
In this work, we have demonstrated two properties of fixed beam radiotherapy. First, the dose distribution of a fixed beam treatment where the target is rotated is equivalent to that of a conventional treatment delivered using a rotating beam. Second, through the use of real-time target localization (KIM) and beam adaptation (MLC tracking) algorithms, the desired dose distribution can be maintained even if a target moves with rotation. These properties represent a proof-ofprinciple for image-guided fixed beam radiotherapy.
The image guidance technologies described in this work are well-suited for a compact fixed beam system as they are primarily a software solution. No specialized hardware is required for its implementation other than the kV imager and MLC found on a conventional linac which allows the system to remain cost-effective. Furthermore, a treatment system built around image guidance can increase the role of automation in radiotherapy. Through the use of image guidance to reduce the stringency of patient alignment and position verification, the time and staff burden of patient setup can be reduced.
The concept of patient rotation, however, brings additional challenges to fixed beam treatments. In the case of horizontal rotation, there will be gravity induced motion in a patient's anatomy as they are rotated to different angles, causing changes in the position of the target and surrounding organs. 16 Barber et al. 17 found in x ray images of anesthetized rabbits under horizontal rotation that organ motion due to gravity was of similar magnitude to organ motion due to respiration. Although intrafraction motion could be managed within the ICRU framework with a margin expansion, we have demonstrated that the real-time image guidance and beam adaptation can more eloquently achieve similar accuracy. To achieve a suitable level of clinical accuracy in the presence of gravity induced motion, the real-time beam adaptation techniques described in this work should be integrated for all treatments on this type of device.
The benefit of this approach is that the inherent advantages of image guidance will improve the overall safety and quality of the treatment. In a fixed beam radiation system, gravity induced motion will be combined with usual physiological motion such as respiratory or gastrointestinal motion. The use of MLC tracking (which has been successfully trialled in patients for a rotating beam geometry 10, 18 and shown here to successfully track phantom movement for a fixed beam geometry) can be used simultaneously compensate for both sources of motion. These treatments can clinically benefit from the ability to reduce the size of clinical margins and the improved dose homogeneity within the target volume. 19 The scaling of the image guidance techniques in this work from a small phantom to a full-size fixed beam treatment system capable of treating human patients presents some unique challenges. For patients rotated horizontally, gravity induced motion would need to be accounted for during imaging, 20 simulation and treatment delivery to bring this treatment method into clinical practice. New upright imaging techniques also enable patients to be rotated along the vertical axis, where less motion would be expected. 21 Further development will also be required to achieve a fully motion adaptive treatment that includes corrections for target deformation and changes to nearby organs at risk as well as dose recalculation.
A prototype fixed beam linear accelerator with a full-size patient rotation system has been installed at the Nelune Comprehensive Cancer Centre in Sydney, Australia 22 and is undergoing development. This full-size fixed beam device will implement the image guidance techniques described in this work to form a treatment system capable of delivering highly precise radiotherapy treatments with the elevated clinical benefits of image guidance, but on a simpler and more cost-effective device. 
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